Hypopituitarism in patients after subarachnoid hemorrhage: screening and treatment - HIPSS

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 180 人开始时间: 待定最近更新: 2024年6月18日

适应症

试验速览

暂无简介。

•Subarachnoid hemorrhage
•Age >= 18 years
•Discharge from ICU
•Signed and dated informed consent document;Controls will be patient-matched on age (+/- 5 years) and gender.

•Any hypothalamic/pituitary disease diagnosed prior to SAH.
•History of cranial irradiation
•Prior significant trauma capitis
•Another significant intracranial lesion (apart from SAH or its sequellae)
•Any other medical or psychiatric condition or laboratory abnormality that may impose a risk for participation in the study or interfere with the interpretation of the study (according to the judgment of the investigators).;Exclusion criteria healthy controls: individuals with deficits which affect physical fitness or activity (eg amputations, hip/knee prosthesis, cognitive problems), individuals at risk for health issues because of maximal testing (according to the Par Q checklist).

发起方